| Successful treatment of isolated cutaneous relapse of follicular lymphoma with rituximab. | |
| | |
MedLine Citation:
|
PMID: 11563595 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Patients with follicular lymphoma (FL) usually present with advanced disease, with lymph nodes and bone marrow involvement. Extranodal infiltration is infrequent. In FL isolated cutaneous relapse is a very rare event that, to the best of our knowledge, has not been previously reported. We report on a 55-year-old woman with FL who presented with an isolated skin relapse 5 years after the diagnosis. The patient, who had relapsed after three lines of chemotherapy, was treated with the chimeric anti-CD20 antibody, rituximab, achieving a complete response, which has now persisted for more than 24 months. |
| | |
Authors:
|
A Ferrer; A López-Guillermo; S Montoto; T Estrach; L Colomo; E Montserrat |
Related Documents
:
|
14597875 - Semi-extended, six weekly rituximab infusions in pre-treated advanced low-grade b cell ... 19021055 - Primary lymphoma of bone: an institutional experience. 18443965 - Profound hypogammaglobulinemia 7 years after treatment for indolent lymphoma. 18186705 - A decade of rituximab: improving survival outcomes in non-hodgkin's lymphoma. 14632775 - Adult t-biphenotypic acute leukaemia: clinical and biological features and outcome. 23107465 - Postprogression survival in patients with advanced non-small-cell lung cancer who recei... |
Publication Detail:
|
Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Annals of hematology Volume: 80 ISSN: 0939-5555 ISO Abbreviation: Ann. Hematol. Publication Date: 2001 Aug |
Date Detail:
|
Created Date: 2001-09-20 Completed Date: 2001-10-04 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 9107334 Medline TA: Ann Hematol Country: Germany |
Other Details:
|
Languages: eng Pagination: 479-81 Citation Subset: IM |
Affiliation:
|
Department of Hematology, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clínic, Barcelona, Spain. alopezg@clinic.ub.es |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Antibodies, Monoclonal
/
therapeutic use* Antineoplastic Agents / therapeutic use* Female Humans Lymphoma, Follicular / drug therapy*, pathology Middle Aged Neoplasm Recurrence, Local / drug therapy*, pathology Skin Neoplasms / drug therapy*, pathology |
| Chemical | |
Reg. No./Substance:
|
0/Antibodies, Monoclonal; 0/Antineoplastic Agents; 0/rituximab |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Absence of clonal chromosomal relationship between concomitant B-CLL and multiple myeloma--a report ...
Next Document: Successful lamivudine therapy for post-chemotherapeutic fulminant hepatitis B in a hepatitis B virus...